Teleflex

US · TFX #2082 by market cap Listed 1970

124.48 -0.26 -0.21%

Live - 5344 symbols - heartbeat 303s ago · 2026-10-08 08:21

Pre-market 123.59 -0.71%

After-hours 124.48 0.00%

Market cap: 5.27B
P/E (TTM): -5.41
P/B: 1.82
EPS: -20.25
Div yield: 1.09%
52W pos: 55%

Reader sentiment Are you bullish or bearish on TFX?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Financial Health how this is computed

Fair

Altman Z-Score is 2.07, in the 1.8-3.0 "grey zone".
Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.

Revenue annual, last 8 years

Latest year +17.25% YoY

Margins

Gross margin: 56.24%
Operating margin: 12.84%
Net margin: -45.45%

Key ratios & quality

Enterprise value: 7.54B
Altman Z-Score: 2.07

Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.

Income statement

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	2.45B	2.60B	2.54B	2.81B	2.79B	1.71B	1.70B	1.99B
Gross profit	1.30B	1.41B	1.32B	1.55B	1.53B	1.04B	1.04B	1.12B
Selling & admin expenses	797.06M	851.77M	743.57M	860.09M	863.75M	622.74M	674.52M	720.17M
Research & development	106.21M	113.86M	119.75M	130.84M	153.82M	113.63M	109.02M	144.78M
Operating profit	399.55M	443.38M	461.56M	558.68M	513.52M	303.75M	253.85M	255.80M
Pretax profit	219.63M	339.90M	357.73M	559.47M	445.92M	185.39M	26.29M	24.55M
Tax	23.20M	-122.08M	21.93M	74.35M	83.00M	41.87M	-30.90M	-33.98M
Net profit	200.80M	461.47M	335.32M	485.37M	363.14M	356.33M	69.68M	-905.64M
Basic EPS	4	10	7	10	8	8	1	-20
Diluted EPS	4.29	9.80	7.09	10.23	7.68	7.53	1.48	-20.30

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
Revenue	414.26M	442.53M	913.02M	-401.87M	548.26M	570.33M
Gross profit	255.43M	265.83M	451.64M	-151.41M	307.43M	331.71M
Selling & admin expenses	152.91M	137.50M	281.76M	614.00K	226.01M	213.52M
Research & development	25.30M	26.49M	57.23M	12.63M	44.39M	45.12M
Operating profit	77.22M	101.84M	112.65M	-164.65M	37.03M	73.07M
Pretax profit	58.75M	70.66M	-438.58M	218.94M	-3.83M	45.14M
Tax	6.42M	2.49M	-29.70M	-30.78M	1.01M	3.38M
Net profit	95.00M	122.58M	-408.89M	-714.33M	-8.15M	99.69M
Basic EPS	2	3	-9	-16	0	2
Diluted EPS	2.07	2.77	-9.24	-16.15	-0.18	2.28

Balance sheet

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Total current assets	1.24B	1.31B	1.42B	1.43B	1.41B	1.41B	1.47B	1.94B
Cash & ST investments	357.16M	301.08M	375.88M	445.08M	292.03M	222.85M	247.85M	378.56M
Inventory	427.78M	476.56M	513.20M	477.64M	578.51M	626.22M	306.77M	404.40M
Total assets	6.28B	6.31B	7.15B	6.87B	6.93B	7.53B	7.10B	6.95B
Total current liabilities	582.46M	563.06M	540.03M	680.12M	581.49M	606.75M	649.36M	762.03M
Short-term debt	86.63M	50.00M	100.50M	110.00M	87.50M	87.50M	100.00M	100.00M
Long-term debt	2.07B	1.86B	2.38B	1.74B	1.62B	1.73B	1.56B	2.54B
Total liabilities	3,738,013,000.00	3,330,500,000.00	3,816,102,000.00	3,116,974,000.00	2,906,095,000.00	3,091,558,000.00	2,819,774,000.00	3,822,471,000.00
Total equity	2.54B	2.98B	3.34B	3.75B	4.02B	4.44B	4.28B	3.12B
Retained earnings	2.43B	2.82B	3.10B	3.52B	3.82B	4.11B	4.12B	3.15B

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
Total current assets	1.54B	1.72B	1.99B	1.94B	1.86B	1.88B
Cash & ST investments	284.12M	253.70M	354.00M	378.56M	309.41M	300.16M
Inventory	643.97M	693.69M	802.47M	404.40M	380.86M	351.91M
Total assets	7.16B	7.38B	7.87B	6.95B	6.78B	6.79B
Total current liabilities	675.91M	716.15M	773.03M	762.03M	728.05M	720.38M
Short-term debt	100.00M	100.00M	100.00M	100.00M	103.13M	87.50M
Long-term debt	1.81B	1.80B	2.57B	2.54B	2.51B	2.72B
Total liabilities	3,068,126,000.00	3,132,351,000.00	4,050,077,000.00	3,822,471,000.00	3,698,566,000.00	3,882,244,000.00
Total equity	4.10B	4.24B	3.82B	3.12B	3.08B	2.90B
Retained earnings	4.20B	4.30B	3.88B	3.15B	3.13B	3.21B

Cash flow

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Operating cash flow	437.38M	439.53M	436.41M	651.42M	342.14M	510.64M	635.74M	340.68M
Depreciation & amortization	209.98M	214.06M	227.25M	237.36M	230.59M	148.11M	161.53M	177.74M
Free cash flow	356.58M	336.83M	345.71M	579.80M	262.95M	464.22M	545.30M	245.44M
Dividends paid	-62.17M	-62.83M	-63.22M	-63.65M	-63.79M	-63.90M	-63.54M	-60.27M
Stock buybacks / issuance	--	0	0	11.10M	0	0	-200.00M	-300.00M
Ending cash balance	357.16M	301.08M	375.88M	445.08M	292.03M	192.73M	285.31M	402.68M

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
Operating cash flow	73.09M	7.74M	107.64M	152.21M	49.02M	94.33M
Depreciation & amortization	38.62M	36.89M	135.46M	-33.23M	53.74M	49.82M
Free cash flow	48.96M	-20.05M	64.97M	151.56M	30.23M	80.30M
Dividends paid	-15.19M	-15.03M	-15.02M	-15.03M	-15.05M	-14.78M
Stock buybacks / issuance	-300.00M	0	0	0	0	-250.00M
Ending cash balance	282.08M	256.56M	381.31M	402.68M	329.55M	316.92M

Returns & efficiency

Line item	2018	2019	2020	2021	2022	2023	2024	2025
ROE %	8.08	16.72	10.62	13.69	9.34	8.42	1.60	-24.47
ROA %	3.22	7.33	4.98	6.92	5.26	4.93	0.95	-12.90
ROIC %	6.23	10.71	7.28	9.18	7.03	6.81	2.26	-14.07
5-year avg ROE %	9.70	11.08	10.71	11.16	11.69	11.76	8.73	1.72
EBIT margin %	13.18	16.19	16.72	21.94	17.92	17.45	5.22	6.26
FCF / sales %	14.56	12.98	13.63	20.64	9.42	14.09	16.71	12.32
Current ratio	2.12	2.32	2.63	2.10	2.43	2.32	2.27	2.54
Quick ratio	1.24	1.28	1.43	1.22	1.21	1.10	0.73	0.95
Debt / assets	34.39	31.86	35.85	28.61	26.44	25.57	24.57	39.23
LT debt / equity	81.58	65.80	73.85	49.43	43.37	41.41	38.42	84.03
Interest coverage	3.13	5.23	6.38	10.82	9.22	6.10	1.90	1.24
Revenue CAGR (3Y) %	10.60	11.58	5.74	4.69	2.45	-12.28	-15.43	-10.62
Net income CAGR (3Y) %	-6.40	24.81	30.03	34.21	-7.68	2.05	-47.64	--
FCF CAGR (3Y) %	14.21	-1.77	-0.31	17.59	-7.92	10.32	-2.02	-2.27

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
ROE %	3.47	4.36	-7.90	-24.47	-28.10	-28.87
ROA %	2.04	2.59	-4.27	-12.90	-14.47	-14.57
ROIC %	3.21	3.92	-4.12	-14.07	-15.98	-16.11
5-year avg ROE %	--	--	--	--	--	--
EBIT margin %	9.62	10.78	-7.22	6.26	3.26	2.22
FCF / sales %	15.94	13.04	8.29	12.32	10.66	14.51
Current ratio	2.28	2.41	2.57	2.54	2.55	2.60
Quick ratio	1.11	1.07	1.22	0.95	0.93	0.92
Debt / assets	27.99	27.05	35.18	39.23	39.59	42.33
LT debt / equity	46.52	44.67	69.84	84.03	83.73	95.89
Interest coverage	3.65	4.10	-2.54	1.24	0.65	0.44
Revenue CAGR (3Y) %	--	--	--	--	--	--
Net income CAGR (3Y) %	--	--	--	--	--	--
FCF CAGR (3Y) %	--	--	--	--	--	--

✦ Quant Revenue Concentration how this is computed

Diversified

Vascular is the largest reported line at 43.19% of revenue, across 3 reported segments.
No single line clears half of revenue; Interventional is next at 37.15%, spreading the business across more than one real driver.

Revenue breakdown most recent period

Business

Vascular43.19%

Interventional37.15%

Surgical19.66%

Quote time 2026-10-08 08:21:55 · For reference only, not investment advice and not tailored to your situation.